FDA 483 - Stryker Medical Division of Stryker Corporation - November 15, 2024

An FDA inspection of Stryker Medical Division of Stryker Corporation in Portage, MI, revealed two significant observations regarding their quality system. The firm failed to adequately establish design verification procedures, specifically concerning worst-case product configuration, and did not adequately validate a critical manufacturing process parameter for the Power Pro 2 device.